Risk assessment of fragility fractures: summary of NICE guidance
| Autor: | Silvia, Rabar, Rosa, Lau, Norma, O'Flynn, Lilian, Li, Peter, Barry, Jonathan, Tobias |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
medicine.medical_specialty Cost effectiveness Osteoporosis Nice Risk management tools Risk Assessment Fragility medicine Humans Intensive care medicine Aged computer.programming_language business.industry General Medicine Middle Aged medicine.disease Surgery Fractures Spontaneous Systematic review Practice Guidelines as Topic Retreatment Female Secondary osteoporosis Risk assessment business computer |
| Zdroj: | BMJ. 345:e3698-e3698 |
| ISSN: | 1756-1833 |
| DOI: | 10.1136/bmj.e3698 |
| Popis: | Osteoporosis is characterised by low bone mass and structural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture, particularly fractures that result from mechanical forces that would not ordinarily result in fracture, known as fragility fractures. The prevalence of osteoporosis rises markedly with age, and in women this rises from 2% at 50 years to more than 25% at 80 years. Risk of fracture is also increased by factors such as lifestyle, drug treatments, family history, and other conditions that cause secondary osteoporosis. Several validated risk assessment tools are available to predict fracture risk. This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on risk assessment of fragility fractures.1 NICE recommendations are based on systematic reviews of the best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the Guideline Development Group’s experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. ### Who needs risk assessment? |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|